Abstract:In an effort to better understand skin development, Han et al. created transgenic mice in which the expression of the inhibitory Smad, Smad7, can be induced in keratinocytes and epidermal stem cells. Smad7 was chosen because its expression is increased in pathological skin conditions. An inducible system was required to allow more precise control of the concentration of Smad7 and because constitutive expression of Smad 7 in keratinocytes of transgenic mice is embryonic lethal. Expression of Smad7 during embryogenesis disrupted hair follicle morphogenesis and differentiation. Expression in adults also inhibited hair follicle growth, promoted sebaceous gland growth, and caused epidermal hyperplasia. At concentrations that produced the effects noted, Smad7 (in the inducible system or in a low expressing constitutive transgenic mouse) did not inhibit transforming growth factor-β (TGF-β) signaling (detected as phosphorylated Smad2) or bone morphogenetic protein (BMP) signaling (detected as phosphorylated Smad 1, 5, and 8) and did not inhibit the expression of some Smad target genes. Thus, Smad7 at the concentrations that caused phenotypic changes was not completely effective in blocking Smad signaling. Wnt and hedgehog signaling are also involved in hair follicle and sebaceous gland development. In skin, increased expression of Smad7 caused a decrease in the abundance of β-catenin, a key component of the Wnt signaling pathway, without altering β-catenin transcription. In Smad7 mice crossed with mice expressing a Wnt reporter gene, less reporter gene expression was visible in the mice in which Smad7 expression was increased. Both acute and prolonged expression of Smad7 decreased the abundance of β-catenin. The authors used cultured cells to show that Smad7 promoted the proteasomal-mediated degradation of β-catenin. Cotransfection experiments suggested that Smad7 recruited the E3 ubiquitin ligase Smurf to β-catenin to mediate ubiquitination of β-catenin. A comparison of aged wild-type skin and skin from 7-month-old Smad7-overexpressing mice showed similar phenotypic skin changes and similar expression levels of the Smad7 transcript. Skin from aged mice also showed a reduction in β-catenin abundance compared with skin from wild-type young mice. All of these results suggest that in skin, at physiological concentrations, Smad7 is a regulator of Wnt signaling rather than TGF-β signaling (see Millar for discussion). G. Han, A. G. Li, Y.-Y. Liang, P. Owens, W. He, S. Lu, Y. Yoshimatsu, D. Wang, P. Ten Dijke, X. Lin, X.-J. Wang, Smad7-induced β-catenin degradation alters epidermal appendage development. Dev. Cell 11 , 301-312 (2006). [PubMed] S. E. Millar, Smad7: Licensed to kill β-catenin. Dev. Cell 11 , 274-276 (2006). [PubMed]

Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis.

A 4.3 Kb Smad7 Promoter is Able to Specify Gene Expression During Mouse Development

Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues.

Sma- and Mad-related Protein 7 (smad7) is Required for Embryonic Eye Development in the Mouse.

Ectopic Expression of Smad7 Inhibits Transforming Growth Factor-Beta Responses in Vascular Smooth Muscle Cells

Targeted Mutagenesis of Smad1 Reveals an Essential Role in Chorioallantoic Fusion

Induction of Inhibitory Smad6 and Smad7 Mrna by Tgf-Beta Family Members

Physical and Functional Interaction of Murine and Xenopus Smad7 with Bone Morphogenetic Protein Receptors and Transforming Growth Factor-β Receptors

Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

The role of Smad signaling in vascular and hematopoietic development revealed by studies using genetic mouse models

Functions of Mammalian Smad Genes As Revealed by Targeted Gene Disruption in Mice

Smad7 Inhibits Wnt Signaling

Smad6 Promotes Neuronal Differentiation In The Intermediate Zone Of The Dorsal Neural Tube By Inhibition Of The Wnt/Beta-Catenin Pathway

Smad7 Enables STAT3 Activation and Promotes Pluripotency Independent of TGF-β Signaling

Distribution of phosphorylated Smad2 identifies target tissues of TGFβ ligands in mouse development

Endogenous Patterns of TGFbeta Superfamily Signaling During Early Xenopus Development.

Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension.

Smad1/5 is acetylated in the dorsal aortae of the mouse embryo before the onset of blood flow, driving early arterial gene expression

Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter.

Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo

Antagonistic Effects of Smad2 Versus Smad7 Are Sensitive to Their Expression Level During Tooth Development.